Purpose of Study
Evaluate the Efficacy and Safety of MEDI6570 in Participants with a prior myocardial infarction
Trial Status
Follow-up
Eligibility Criteria
Participant must be 30 to 180 days post -MI at screening visit, 40 years of age or older
Duration of Participation
Approximately 15 months
Contact Name: Donna Prouty, RN
Contact Phone: 515-633-3848
Contact Email: dprouty@iowaheart.com